CohBar Inc (CWBR)
0.49
-0.02
(-4.02%)
USD |
OTCM |
Nov 13, 16:00
CohBar Max Drawdown (5Y): 99.83% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 99.83% |
September 30, 2024 | 99.83% |
August 31, 2024 | 99.83% |
July 31, 2024 | 99.83% |
June 30, 2024 | 99.58% |
May 31, 2024 | 99.54% |
April 30, 2024 | 99.54% |
March 31, 2024 | 99.54% |
February 29, 2024 | 99.54% |
January 31, 2024 | 99.54% |
December 31, 2023 | 99.54% |
November 30, 2023 | 99.54% |
October 31, 2023 | 99.54% |
September 30, 2023 | 99.54% |
August 31, 2023 | 99.54% |
July 31, 2023 | 99.54% |
June 30, 2023 | 99.54% |
May 31, 2023 | 99.54% |
April 30, 2023 | 99.54% |
March 31, 2023 | 99.54% |
February 28, 2023 | 99.52% |
January 31, 2023 | 99.52% |
December 31, 2022 | 99.52% |
November 30, 2022 | 99.52% |
October 31, 2022 | 99.33% |
Date | Value |
---|---|
September 30, 2022 | 99.08% |
August 31, 2022 | 98.53% |
July 31, 2022 | 98.33% |
June 30, 2022 | 98.33% |
May 31, 2022 | 98.30% |
April 30, 2022 | 97.60% |
March 31, 2022 | 97.60% |
February 28, 2022 | 97.50% |
January 31, 2022 | 97.21% |
December 31, 2021 | 96.71% |
November 30, 2021 | 95.29% |
October 31, 2021 | 94.62% |
September 30, 2021 | 91.66% |
August 31, 2021 | 91.66% |
July 31, 2021 | 91.66% |
June 30, 2021 | 91.66% |
May 31, 2021 | 91.66% |
April 30, 2021 | 91.66% |
March 31, 2021 | 91.66% |
February 28, 2021 | 91.66% |
January 31, 2021 | 91.66% |
December 31, 2020 | 91.66% |
November 30, 2020 | 91.66% |
October 31, 2020 | 91.66% |
September 30, 2020 | 91.66% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.46%
Minimum
Nov 2019
99.83%
Maximum
Jul 2024
95.78%
Average
97.95%
Median
Max Drawdown (5Y) Benchmarks
CEL-SCI Corp | 96.78% |
AIM ImmunoTech Inc | 99.61% |
IGC Pharma Inc | 97.77% |
NovaBay Pharmaceuticals Inc | 99.98% |
Protalix BioTherapeutics Inc | 94.35% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -81.88 |
Beta (5Y) | 1.372 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 115.7% |
Historical Sharpe Ratio (5Y) | -0.5549 |
Historical Sortino (5Y) | -1.153 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.72% |